Terms: = Breast cancer AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Prognosis
99 results:
1. Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks.
Qu N; Chen D; Ma B; Zhang L; Wang Q; Wang Y; Wang H; Ni Z; Wang W; Liao T; Xiang J; Wang Y; Jin S; Xue D; Wu W; Wang Y; Ji Q; He H; Piao HL; Shi R
Nat Commun; 2024 Apr; 15(1):3175. PubMed ID: 38609408
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
[TBL] [Abstract] [Full Text] [Related]
3. Assessing the Therapeutic Impacts of HAMLET and FOLFOX on braf-Mutated Colorectal cancer: A Study of cancer Cell Survival and Mitochondrial Dynamics In Vitro and Ex Vivo.
Žilinskas J; Stukas D; Jasukaitienė A; Žievytė I; Balion Z; Šapauskienė J; Banienė R; Paužas H; Lizdenis P; Čėsna V; Dambrauskas Ž; Gulbinas A; Tamelis A
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256402
[No Abstract] [Full Text] [Related]
4. Risk factors for central lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
Du J; Yang Q; Sun Y; Shi P; Xu H; Chen X; Dong T; Shi W; Wang Y; Song Z; Shang X; Tian X
Front Endocrinol (Lausanne); 2023; 14():1288527. PubMed ID: 38047112
[TBL] [Abstract] [Full Text] [Related]
5. Omics sciences and precision medicine in thyroid cancer.
Dhuli K; Medori MC; Donato K; Donato K; Maltese PE; Tanzi B; Tezzele S; Mareso C; Miertus J; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Beccari T; Ceccarini MR; Stuppia L; Stuppia L; Gatta V; Cristoni S; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):11-20. PubMed ID: 37994744
[TBL] [Abstract] [Full Text] [Related]
6. A visualized model for identifying optimal candidates for aggressive locoregional surgical treatment in patients with bone metastases from breast cancer.
Tong Y; Xu S; Jiang L; Zhao C; Zhao D
Front Endocrinol (Lausanne); 2023; 14():1266679. PubMed ID: 37867528
[TBL] [Abstract] [Full Text] [Related]
7. Genetic Aspects of Conjunctival Melanoma: A Review.
Chang E; Demirci H; Demirci FY
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761808
[TBL] [Abstract] [Full Text] [Related]
8. Mutation Profile via Next-Generation Sequencing in Patients with Colorectal Adenocarcinoma and Its Clinicopathological Correlation.
Osman S; Kahraman Çetin N; Erdoğdu İH; Meteoğlu İ
Turk J Gastroenterol; 2023 Nov; 34(11):1124-1133. PubMed ID: 37737217
[TBL] [Abstract] [Full Text] [Related]
9. High Atlastin 2-2 (ATL2-2) Expression Associates with Worse prognosis in Estrogen-Receptor-Positive breast cancer.
Reynisdottir I; Arason A; Freysteinsdottir ES; Kristjansdottir SB; Hilmarsdottir B; Traustadottir GA; Johannsson OT; Agnarsson BA; Barkardottir RB
Genes (Basel); 2023 Jul; 14(8):. PubMed ID: 37628611
[TBL] [Abstract] [Full Text] [Related]
10. Development and validation of prognostic nomogram for T
Mei W; Yao W; Song Z; Jiao W; Zhu L; Huang Q; An C; Shi J; Yu G; Sun P; Zhang Y; Shen J; Xu C; Yang H; Wang Q; Zhu Z
BMC Cancer; 2023 Jul; 23(1):715. PubMed ID: 37525124
[TBL] [Abstract] [Full Text] [Related]
11. Identification of Serpin peptidase inhibitor clade A member 1 (SERPINA1) might be a poor prognosis biomarker promoting the progression of papillary thyroid cancer.
Li Q; Dong X; Jin G; Dong Y; Yu Y; Jin C; Huang X
Life Sci; 2023 Sep; 329():121938. PubMed ID: 37487942
[TBL] [Abstract] [Full Text] [Related]
12. Budding uninhibited by benzimidazoles 1 might be a poor prognosis biomarker promoting the progression of papillary thyroid cancer.
Jiang W; Yu Y; Bhandari A; Hirachan S; Dong X; Huang X; Qu J; Chen C
Environ Toxicol; 2023 Sep; 38(9):2047-2056. PubMed ID: 37163344
[TBL] [Abstract] [Full Text] [Related]
13. Molecular Profiling Provides Clinical Insights Into Targeted and Immunotherapies as Well as Colorectal cancer prognosis.
Guo L; Wang Y; Yang W; Wang C; Guo T; Yang J; Shao Z; Cai G; Cai S; Zhang L; Hu X; Xu Y
Gastroenterology; 2023 Aug; 165(2):414-428.e7. PubMed ID: 37146911
[TBL] [Abstract] [Full Text] [Related]
14. Molecular Pathology of Micropapillary Carcinomas: Is Characteristic Morphology Related to Molecular Mechanisms?
Sagnak Yilmaz Z; Sarioglu S
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):267-277. PubMed ID: 37036419
[TBL] [Abstract] [Full Text] [Related]
15. Multi-omics profiling of papillary thyroid microcarcinoma reveals different somatic mutations and a unique transcriptomic signature.
Li Q; Feng T; Zhu T; Zhang W; Qian Y; Zhang H; Zheng X; Li D; Yun X; Zhao J; Li Y; Yu H; Gao M; Qian B
J Transl Med; 2023 Mar; 21(1):206. PubMed ID: 36941725
[TBL] [Abstract] [Full Text] [Related]
16. A reversible SRC-relayed COX2 inflammatory program drives resistance to braf and EGFR inhibition in braf
Ruiz-Saenz A; Atreya CE; Wang C; Pan B; Dreyer CA; Brunen D; Prahallad A; Muñoz DP; Ramms DJ; Burghi V; Spassov DS; Fewings E; Hwang YC; Cowdrey C; Moelders C; Schwarzer C; Wolf DM; Hann B; VandenBerg SR; Shokat K; Moasser MM; Bernards R; Gutkind JS; van 't Veer LJ; Coppé JP
Nat Cancer; 2023 Feb; 4(2):240-256. PubMed ID: 36759733
[TBL] [Abstract] [Full Text] [Related]
17. Papillary thyroid cancer organoids harboring braf
Chen D; Su X; Zhu L; Jia H; Han B; Chen H; Liang Q; Hu C; Yang H; Liu L; Li P; Wei W; Zhao Y
J Transl Med; 2023 Jan; 21(1):9. PubMed ID: 36624452
[TBL] [Abstract] [Full Text] [Related]
18. prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project.
Bridgewater J; Jiao X; Parimi M; Flach C; Stratford J; Kamburov A; Schmitz AA; Zong J; Reeves JA; Keating K; Bruno A; Fellous M; Pereira MB; Bazhenova L
Cancer Treat Res Commun; 2022; 33():100623. PubMed ID: 36041373
[TBL] [Abstract] [Full Text] [Related]
19. Clinical significance of multi-genic assay in identifying aggressive papillary thyroid carcinoma.
Tang L; Shu X; Hu D; Deng C; Ren H; Su X
Am J Otolaryngol; 2022; 43(5):103563. PubMed ID: 35961219
[TBL] [Abstract] [Full Text] [Related]
20. Metastatic malignant melanoma of the breast: report of a case and review of the literature.
Mastoraki A; Gkiala A; Theodoroleas G; Mouchtouri E; Strimpakos A; Papagiannopoulou D; Schizas D
Folia Med (Plovdiv); 2022 Apr; 64(2):354-358. PubMed ID: 35851793
[TBL] [Abstract] [Full Text] [Related]
[Next]
